Questcor Pharmaceuticals Buys BioVectra

QuestCor Pharmaceuticals, the Anaheim-based biopharmaceuticals firm providing treatments for autoimmune and inflammatory disorders, said yetserday that it has acquired BioVectra, a supplier of contract manufacturing services to the pharmaceuticals and biotechnology industry. The deal was worth approximately $50.7M (C$50M). BioVectra has been Questcor's manufacturing partner for nearly a decade, and is based in Prince Edward Island, Canada.